Remove Clinical Supply Remove Contract Manufacturing Remove Licensing Remove Medicine
article thumbnail

Abiogen acquires EffRx to fortify bone disease portfolio

Pharmaceutical Technology

The European Medicines Agency has also approved Efmody for the treatment of congenital adrenal hyperplasia medicine in patients ages 12 years and above in the European Union. Separate from drug development, the Italian company also offers contract manufacturing and clinical supply services.